Procedure dossier
Kybella
Injectable deoxycholic acid treatment for submental fat reduction
Kybella is the first and only FDA-approved injectable treatment for the reduction of moderate to severe submental fat, commonly known as a double chin [2]. The active ingredient, synthetic deoxycholic acid, is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat [2]. When injected into the fat beneath the chin, Kybella permanently destroys fat cells, resulting in a noticeable reduction in fullness and a more defined chin and jawline profile.
The treatment involves a series of small injections administered directly into the submental fat pad during an in-office visit. Each treatment session takes approximately 15 to 20 minutes, and most patients require two to four sessions spaced at least one month apart to achieve optimal results [2]. Once the desired aesthetic outcome is reached, retreatment is not expected because the destroyed fat cells can no longer store or accumulate fat.
Kybella provides a non-surgical alternative to liposuction for patients bothered by submental fullness who prefer to avoid surgery [1]. The treatment is particularly appealing to patients who have a localized pocket of fat beneath the chin that does not respond to diet and exercise, but who have adequate skin elasticity for the skin to retract as the underlying fat volume decreases.
Average range
$1,200 - $3,000
Recovery
2 weeks
Duration
0.5 hours
Anesthesia
Local
Complexity
Simple
Category
Nonsurgical
01 / The brief
What to know first
Deoxycholic acid is a secondary bile acid formed by intestinal bacteria through modification of the primary bile acid cholic acid, which is produced by the liver. After formation in the gut, deoxycholic acid is reabsorbed and recirculated through enterohepatic circulation. It plays a key role in the emulsification and absorption of dietary fats in the small intestine. The synthetic form used in Kybella (ATX-101) is bioequivalent to the endogenous molecule and functions through the same mechanism -- disrupting the cell membrane of adipocytes (fat cells), causing them to lyse and die.
Kybella received FDA approval in April 2015 following extensive clinical trials involving more than 2,600 subjects, of which over 1,600 received Kybella treatment [2]. The pivotal REFINE studies demonstrated that patients treated with Kybella showed significant improvement in submental fullness compared to placebo, with 68.2% of patients experiencing at least a one-grade improvement on the clinician-reported Submental Fat Rating Scale [2]. Patient satisfaction rates were high, with the majority reporting improved self-perception of their appearance.
The mechanism of action involves direct cytolysis of fat cells upon contact with deoxycholic acid. Following injection, the cell membranes of adipocytes in the treatment area are disrupted, releasing their lipid contents. This triggers an inflammatory response as macrophages and other immune cells clear the cellular debris and liberated fat. The inflammatory process also stimulates a fibrotic response, with new collagen deposition providing a degree of tissue tightening in the treated area.
The body processes the released lipids through the same metabolic pathways used for dietary fat. The lipids are transported via the lymphatic system and bloodstream to the liver for processing. Clinical studies have shown that Kybella treatments do not significantly affect serum lipid levels, liver function tests, or other metabolic parameters.
Each Kybella treatment session involves 10 to 50 injections, with each injection delivering 0.2 mL of the solution. The maximum recommended dose per session is 10 mL (50 injections) [2]. The number of injections per session and the total number of sessions required are determined by the amount and distribution of submental fat and the patient's aesthetic goals. Up to six treatment sessions may be administered, spaced at least one month apart [2].
02 / Approaches
Techniques and options
The Kybella injection procedure begins with thorough assessment of the submental area. The provider evaluates the amount of submental fat, skin laxity, presence of platysmal banding, and the patient's overall facial and neck anatomy. A grid pattern is marked on the treatment area using a temporary tattoo or surgical marker, with injection sites spaced 1 cm apart. This grid ensures even distribution of the deoxycholic acid throughout the targeted fat layer.
Local anesthesia is administered before the injections, typically through topical application of a numbing cream and/or ice for 15 to 20 minutes. Some providers also inject local anesthetic along the treatment border. Using a small-gauge needle (typically 30 gauge), the provider administers 0.2 mL of Kybella per injection point, targeting the preplatysmal fat layer. Proper injection depth is critical -- too superficial may cause skin necrosis, and too deep may injure the marginal mandibular nerve.
The provider carefully avoids the marginal mandibular nerve, which runs along the lower border of the mandible and controls movement of the lower lip. Injection sites are kept within the defined boundaries of the submental fat pad, well below the mandibular margin. The platysma muscle serves as the deep boundary, with injections placed into the fat superficial to this muscle.
Immediately after injection, the provider applies gentle pressure to the treatment area and the patient is monitored briefly for any adverse reactions. Ice packs are provided to manage initial swelling and discomfort.
03 / Candidacy
Who may be a candidate
Often considered
Ideal candidates for Kybella are adults with moderate to severe submental fullness -- a visible pocket of fat beneath the chin -- who desire a more defined chin and jawline without surgery. Good candidates have adequate skin elasticity to allow the skin to retract as the underlying fat volume decreases. They should be at or near a stable weight and understand that Kybella is not a weight loss treatment.
Patients who are bothered by their double chin in photos, feel self-conscious about their profile, or find that diet and exercise have not reduced the fullness beneath their chin are excellent candidates. Those who prefer a gradual, non-surgical approach and are willing to undergo multiple treatment sessions are well-suited for Kybella.
Reasons to pause
Kybella is not suitable for patients whose submental fullness is primarily due to skin laxity, platysmal banding, or an under-projected chin rather than excess fat. These conditions require different treatments such as skin tightening, surgical neck lift, or chin augmentation. A thorough evaluation by a qualified provider is necessary to determine the underlying cause of submental fullness.
Patients with active infections in the treatment area, difficulty swallowing, or bleeding disorders should not receive Kybella. Those who have had prior surgical or aesthetic treatment to the submental area should disclose this history, as scarring or altered anatomy may affect treatment safety and results. Pregnant and breastfeeding women should avoid treatment. Patients who cannot tolerate significant swelling for two to four weeks after each session or who need rapid results are better served by surgical alternatives.
04 / Tradeoffs
Potential benefits and risks
Potential benefits
Kybella offers a non-surgical solution for a specific cosmetic concern that has historically required surgical intervention. The ability to permanently reduce submental fat through a series of brief office visits, without incisions, anesthesia, or significant recovery, is a unique advantage that appeals to many patients.
The permanent destruction of fat cells means that once the desired profile is achieved, the results are lasting without the need for ongoing maintenance treatments. This distinguishes Kybella from many other nonsurgical cosmetic procedures that require periodic repeat treatments.
Treatment sessions are quick, typically lasting 15 to 20 minutes, and can be scheduled during a lunch break or between other obligations. While swelling after each session is noticeable, the procedure does not require time away from work for most patients. Kybella can be combined with other aesthetic treatments, including Botox and dermal fillers, as part of a comprehensive facial rejuvenation plan.
The treatment is highly targeted, treating only the specific area of concern without affecting surrounding structures when properly administered.
Risks to discuss
The most common side effect of Kybella is swelling in the treated area, which can be significant and typically peaks at 24 to 72 hours after treatment. Swelling gradually subsides over two to four weeks. This post-treatment swelling is a normal part of the inflammatory process by which the body clears the destroyed fat cells.
Other common side effects include bruising, pain, numbness, redness, and areas of hardness or firmness in the treatment area. These effects are generally mild to moderate and resolve within two to four weeks. A tingling or burning sensation during and immediately after injection is expected as the deoxycholic acid contacts the tissue.
Marginal mandibular nerve injury is the most significant risk specific to Kybella, occurring in approximately 4% of patients in clinical trials [2]. This nerve controls lower lip movement, and injury can cause an asymmetric smile or difficulty with lip function. The injury is typically temporary, resolving within one to three months in most cases, but permanent nerve damage is possible [2].
Skin necrosis (tissue death) can occur if the product is injected too superficially. Dysphagia (difficulty swallowing) has been reported rarely and is generally mild and temporary. Injection site alopecia (hair loss) at the treatment area has been reported. Uneven results or the need for additional sessions beyond the planned number are possible.
05 / Planning
Preparation and recovery
Before the procedure
Avoid blood-thinning medications and supplements for seven to ten days before treatment, including aspirin, ibuprofen, naproxen, vitamin E, fish oil, and ginkgo biloba. Consult your prescribing physician before discontinuing any prescribed medications. Avoid alcohol for 24 to 48 hours before the appointment.
Arrive with a clean neck and chin area, free of makeup and skincare products. Inform your provider of any previous treatments to the submental area, including liposuction, CoolSculpting, or other procedures. Discuss any history of difficulty swallowing or nerve conditions.
Plan your schedule around the expected swelling, which can be quite pronounced for the first one to two weeks after treatment. While you can return to work the same day, some patients prefer to schedule treatments before a weekend or when they have lighter social commitments. Take before photos from multiple angles so you can track your progress across treatment sessions.
Aftercare
After Kybella treatment, apply ice or cold compresses to the treated area for 10 to 15 minutes at a time to manage swelling and discomfort. Over-the-counter pain medication such as acetaminophen can help with any pain. Avoid aspirin and ibuprofen for 24 hours after treatment if possible, as they may increase bruising.
Expect significant swelling that may make the treatment area appear temporarily larger than before. This is a normal and expected response. Swelling peaks at two to three days and gradually resolves over two to four weeks. Some patients describe a "bullfrog" appearance in the first few days, which is entirely normal.
Avoid strenuous exercise, excessive heat exposure, and alcohol for 48 hours after treatment. Do not massage or manipulate the treated area. Sleep with your head elevated for the first few nights to help manage swelling. Resume normal skincare routines as the area heals, and apply sunscreen if the area will be exposed to sunlight. Attend your scheduled follow-up appointment to assess results and plan subsequent treatment sessions.
Significant swelling and possible bruising; area may feel firm, numb, or tender
Swelling beginning to subside; bruising fading
Noticeable reduction in swelling; treated area softening
Swelling fully resolved; initial contouring improvement visible
Continued fat cell elimination; progressive improvement in profile
Full results from treatment series apparent after multiple sessions
Expected results
Results from Kybella develop gradually as the body processes the destroyed fat cells. Significant swelling occurs after each treatment session, temporarily enlarging the treated area before it subsides over two to four weeks. Initial contouring improvement typically becomes visible four to six weeks after the first treatment. With each subsequent session, the cumulative fat reduction becomes more apparent.
Most patients achieve their desired result after two to four treatment sessions, though some may require up to six sessions for optimal improvement. In clinical trials, 79% of Kybella-treated patients reported improved satisfaction with their appearance, compared to 34% in the placebo group [2]. Most patients required two to four treatment sessions, though some received up to six sessions for optimal improvement.
Once the targeted fat cells are destroyed, they do not regenerate. This means that once the desired result is achieved, further treatment is not typically needed as long as the patient maintains a stable weight. Significant weight gain after treatment can cause remaining fat cells in the area to enlarge, potentially diminishing the cosmetic improvement.
06 / Common questions
Frequently asked
How many Kybella treatments will I need?
Most patients require two to four treatment sessions to achieve their desired result, with each session spaced at least one month apart. The number of sessions depends on the amount of submental fat present and your aesthetic goals. Some patients see satisfactory improvement after just two sessions, while others may need up to six. Your provider will develop a personalized treatment plan during your consultation and adjust the number of sessions based on your progress. Each treatment session involves 10 to 50 small injections and takes approximately 15 to 20 minutes.
Is the fat reduction from Kybella permanent?
Yes, Kybella permanently destroys fat cells in the treated area. Once these cells are eliminated, they cannot store or accumulate fat again. Clinical studies confirm that patients who achieved their desired result did not require further treatment for up to three years of follow-up. However, significant weight gain after treatment can cause the remaining fat cells in the area to enlarge, potentially reducing the cosmetic benefit. Maintaining a stable weight through healthy lifestyle habits helps ensure long-lasting results.
How much swelling should I expect after Kybella?
Swelling after Kybella is the most prominent side effect and is a normal part of the treatment process. Most patients experience moderate to significant swelling that peaks at two to three days after treatment. The area beneath the chin may appear noticeably enlarged, and some patients describe a "bullfrog" appearance during the first few days. Swelling gradually subsides over two to four weeks. The degree of swelling varies by individual and tends to be most pronounced after the first session. Cold compresses and head elevation help manage swelling.
07 / Community desk
Ask about kybella
Sources and standards